Editors' Pick

Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.

Bonet-Costa V, Herranz-Pérez V, Blanco-Gandía MC, Mas-Bargues C, Inglés M, Garcia-Tarraga P, Rodriguez-Arias M, Miñarro J, Borras C, Garcia-Verdugo JManuel, et al.
J Alzheimers Dis. 2016; 51(3):701-11. PMID: 26890773. Abstract